Interestingly, previous studies in breast cancer have demonstrated that nuclear staining of GLI1 in cancer cells is associated with aggressive tumor characteristics (i.e., tumor stage and lymph node status) [18], early recurrence, and poor prognosis [23,24]. This evidence concerns the gene GLI1 and breast carcinoma.